These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 31693726)
21. Location of the BCR/ABL fusion genes on both chromosomes 9q34 in Ph negative chronic myeloid leukemia. Michalová K; Zemanová Z; Bkezinová J; Moravcová J; Oltová A; Sobotka J; Kuglík P; Kozak T; Sindelarová L; Jankovská M; Obomilová A; Sieglová Z; Polák J; Nádvorníková S; Haskovec C Leuk Lymphoma; 2002 Aug; 43(8):1695-700. PubMed ID: 12400616 [TBL] [Abstract][Full Text] [Related]
22. Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression. Bacher U; Haferlach T; Hiddemann W; Schnittger S; Kern W; Schoch C Cancer Genet Cytogenet; 2005 Feb; 157(1):53-61. PubMed ID: 15676148 [TBL] [Abstract][Full Text] [Related]
23. The cytogenetic scenario of chronic myeloid leukemia. Mitelman F Leuk Lymphoma; 1993; 11 Suppl 1():11-5. PubMed ID: 8251885 [TBL] [Abstract][Full Text] [Related]
24. [A molecular cytogenetic study on chromosome anomalies of chronic myeloid leukemia]. Zhu B; Shen X; Li C; Lai X; Li Y; Shi K; Feng H; Wang R Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):116-8. PubMed ID: 10751535 [TBL] [Abstract][Full Text] [Related]
25. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript. Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251 [TBL] [Abstract][Full Text] [Related]
26. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia. Steinberg M Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072 [TBL] [Abstract][Full Text] [Related]
27. Additional chromosomal abnormalities in Philadelphia positive chronic myeloid leukemia. Tashfeen S; Mahmood R; Khan SA; Khadim T Pak J Med Sci; 2020; 36(2):208-212. PubMed ID: 32063961 [TBL] [Abstract][Full Text] [Related]
28. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias. Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919 [TBL] [Abstract][Full Text] [Related]
29. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21. Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917 [TBL] [Abstract][Full Text] [Related]
30. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature. Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493 [TBL] [Abstract][Full Text] [Related]
31. Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. Ko BS; Tang JL; Lee FY; Liu MC; Tsai W; Chen YC; Wang CH; Sheng MC; Lin DT; Lin KH; Tien HF Am J Hematol; 2002 Dec; 71(4):291-9. PubMed ID: 12447959 [TBL] [Abstract][Full Text] [Related]
32. The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia. Weinstein ME; Grossman A; Perle MA; Wilmot PL; Verma RS; Silver RT; Arlin Z; Allen SL; Amorosi E; Waintraub SE Cancer Genet Cytogenet; 1988 Oct; 35(2):223-9. PubMed ID: 3180023 [TBL] [Abstract][Full Text] [Related]
33. Cytogenetic investigation in chronic myeloid leukemia: study from an Indian population. Chavan D; Ahmad F; Iyer P; Dalvi R; Kulkarni A; Mandava S; Das BR Asian Pac J Cancer Prev; 2006; 7(3):423-6. PubMed ID: 17059336 [TBL] [Abstract][Full Text] [Related]
34. Chronic myeloid leukemia: Relevance of cytogenetic and molecular assays. Bennour A; Saad A; Sennana H Crit Rev Oncol Hematol; 2016 Jan; 97():263-74. PubMed ID: 26412717 [TBL] [Abstract][Full Text] [Related]
35. Cytogenetic, fluorescence in situ hybridization, and genomic array characterization of chronic myeloid leukemia with cryptic BCR-ABL1 fusions. Shao L; Miller S; Keller-Ramey J; Zhang Y; Roulston D Cancer Genet; 2015; 208(7-8):396-403. PubMed ID: 26186983 [TBL] [Abstract][Full Text] [Related]
36. Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation. Nishigaki H; Misawa S; Inazawa J; Abe T Leukemia; 1992 May; 6(5):385-92. PubMed ID: 1593904 [TBL] [Abstract][Full Text] [Related]
37. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia]. Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504 [TBL] [Abstract][Full Text] [Related]
38. Clonal chromosomal aberrations in Philadelphia negative cells such as monosomy 7 and trisomy 8 may persist for years with no impact on the long term outcome in patients with chronic myeloid leukemia. Wasilewska EM; Panasiuk B; Gniot M; Sawicka A; Kozłowska K; Lewandowski K; Kłoczko J; Midro AT Cancer Genet; 2017 Oct; 216-217():1-9. PubMed ID: 29025581 [TBL] [Abstract][Full Text] [Related]
39. Location of the BCR/ABL Fusion Genes on Both Chromosomes 9 in Ph Negative Young CML Patients: An Indian Experience. Brahmbhatt MM; Trivedi PJ; Patel DM; Shukla SN; Patel PS Indian J Hematol Blood Transfus; 2014 Dec; 30(4):241-6. PubMed ID: 25435721 [TBL] [Abstract][Full Text] [Related]
40. Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive. Yehuda O; Abeliovich D; Ben-Neriah S; Sverdlin I; Cohen R; Varadi G; Orr R; Ashkenazi YJ; Heyd J; Lugassy G; Ben Yehuda D Cancer Genet Cytogenet; 1999 Oct; 114(2):100-7. PubMed ID: 10549264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]